Hormone therapy: Is it right for you?
Army to deny hormone therapy to Chelsea Manning, the convicted private formerly known as Bradley, “raises serious constitutional concerns” and may be in violation of the Eigth Amendment. The ACLU posted its response to the Army on its website: In response to Chelsea Manning’s disclosure that she is female, has been diagnosed with gender dysphoria and will be seeking hormone therapy as a part of her transition during her incarceration, public statements by military officials that the Army does not provide hormone therapy to treat gender dysphoria raise serious constitutional concerns. Gender dysphoria is a serious medical condition in which a person’s gender identity does not correspond to his or her assigned sex at birth, and hormone therapy is part of the accepted standards of care for this condition. Without the necessary treatment, gender dysphoria can cause severe psychological distress, including anxiety and suicide. When the government holds individuals in its custody, it must provide them with medically necessary care. The official policy of the Federal Bureau of Prisons and most state agencies is to provide medically necessary care for the treatment of gender dysphoria, and courts have consistently found that denying such care to prisoners based on blanket exclusions violates the Eighth Amendment of the Constitution.
For the original version including any supplementary images or video, visit http://livewire.talkingpointsmemo.com/entry/aclu-denying-hormone-therapy-to-manning-raises-serious
Government panel: Hormone therapy ‘not recommended’
“In the face of pretty good evidence, the balance of potential benefits and potential harms leads us not to recommend the use of these therapies,” said Dr. Kirsten Bibbins-Domingo, a task force member. The proposed recommendations do not apply to women younger than 50 who have undergone surgical menopause or who are taking hormone therapy to manage menopausal symptoms such as hot flashes, according to the panel. Government panel: HRT ‘not recommended’ “No shock there,” said Dr. Carolyn Crandall, a professor of medicine at the David Geffen School of Medicine at UCLA. “I don’t think the recommendations are surprising at all.” The question used to shape the draft recommendations, which were posted online Tuesday , is whether hormone therapy should be used by menopausal women to prevent a hypothetical future health event such as heart disease or cognitive decline, Bibbins-Domingo said.
For the original version including any supplementary images or video, visit http://www.cnn.com/2012/05/29/health/conditions/hormone-replacement-therapy/
Hormone therapy, calcium may lower fracture risk
Thank you for your question! It will be reviewed and considered for posting on CNNHealth.com. Questions and comments are moderated by CNN and will not appear until after they have been reviewed and approved. Unfortunately, because of the voume of questions we receive, not all can be posted.
For the original version including any supplementary images or video, visit http://www.cnn.com/HEALTH/library/hormone-therapy/WO00046.html
In one arm of the trial, participants were randomly assigned to take either hormone therapy or a drug-free placebo. In another, they took 1,000 milligrams of calcium and 400 IU of vitamin D or placebo tablets each day. About 16,000 women were part of both the hormone and vitamin trials, including 4,000 randomized to both hormone therapy – either estrogen alone or estrogen and progesterone – and calcium and vitamin D. In total, 214 women had a hip fracture during the study. The researchers found that women assigned to both the hormone therapy and vitamin groups were about half as likely to have a fracture as those in the placebo groups.
For the original version including any supplementary images or video, visit http://www.reuters.com/article/2013/06/28/us-hormone-therapy-idUSBRE95R0YN20130628